Viridian Capital Advisors - Spark Newswire

2 minute read

Cannabis Stocks: Are US MSO Multiples Too Low?

Today, 5:37 AM

Are Cannabis multiples too low, and how do we know? To answer this question, we collected and summarized data on 266 companies across nine different industries, which we believe to be the most similar to cannabis. Tobacco and alcohol, for example, are both frequently mentioned in this context.

CRLBF

18 minute read

Outperforming Cannabis Stocks Without Federal Legislation: These Top MSO Picks Will Surprise You

By Viridian Capital Advisors

Today, 5:37 AM

As mentioned last week, we feel federal cannabis legislation is unlikely to come this year with a more realistic timeframe for legislation being next Summer or Fall when Democrats have a better sense of where they will stand coming out of the mid-term elections.

AAWH

2 minute read

Cannabis Industry Chart Of The Week: Q2 Earnings Releases Have Failed To Rally Marijuana Stocks

By Viridian Capital Advisors

Today, 5:37 AM

Last week seven of the eleven MSOs with more than $1B market caps reported Q2 results. The chart shows the percentage difference between actual Revenue and EBITDA versus consensus analyst estimates, and the percent change of the stocks post announcement.

CURLF

1 minute read

British American Tobacco’s Btomorrow Ventures Leads $25.4M Series A For Cannabinoid Biotech Co. Trait Bio

By Viridian Capital Advisors

Today, 5:37 AM

Trait Biosciences, a leading cannabinoid biotechnology research organization, announced that it has completed a C$31 million ($25.46 million) Series A financing round led by the corporate venturing unit of British American Tobacco (NYSE: BTI), Btomorrow Ventures, and backed by Gotham Green Partners.

BTI